<DOC>
	<DOCNO>NCT01148940</DOCNO>
	<brief_summary>The purpose trial investigate D-Dimer level , surrogate marker venous thromboembolism , pregnant/postpartum white woman compare pregnant/postpartum black woman , pregnant/postpartum woman sickle cell trait . The investigator determine whether increase D-Dimer level reflect great incidence thrombosis postpartum patient , well prevalence symptomatic venous thrombosis black patient compare pregnant white patient woman sickle cell trait . The investigator also investigate effect blood group parameter . If evidence increase risk thrombosis sickle cell trait , investigator plan trial prophylactic anticoagulation last trimester four week post partum patient sickle cell trait compare population patient receive prophylactic anticoagulation .</brief_summary>
	<brief_title>Sickle Cell Trait Risk Venous Thromboembolism</brief_title>
	<detailed_description>Venous thromboembolism major cause maternal mortality United States emerge data thrombotic risk high peripartum black woman compare white woman . The reason unclear : indeed , genetic risk factor venous thrombosis identify common white black . This raise possibility yet undescribed mutation . To bolster theory , intrigue study note similar frequency 'familial ' thrombosis black white , support existence yet unidentified hereditary component ( ) . Sickle cell anemia genetic disease prevalent black population . Whereas sickle cell anemia associate prothrombotic state , limit data support prothrombotic state sickle cell trait . We plan examine whether sickle cell trait might play role increase incidence thrombosis black population . Peripartum woman 4-5 time likely develop venous thrombosis . Scant literature exist thrombotic risk woman different race peripartum period study evaluate venous thrombosis risk sickle cell trait woman time increase thrombogenicity . In retrospective analysis delivery 12,000 woman Einstein/Montefiore , high incidence venous thrombosis black peripartum woman observe , among black population , trend sickle cell trait woman high risk compare black woman normal hemoglobin ( Hb ) AA . Given medical importance financial/sociological impact venous thrombosis , important determine whether black woman , specifically black woman sickle cell trait , really increase risk thromboembolic disease peripartum period , , intervention ( ) might mitigate risk . We propose perform prospective study investigate peripartum white Hb AA , black Hb AA , black sickle cell trait woman assess D-Dimer level . The D-Dimer level assay define time peripartum correlate pregnancy complication , well neonatal birth data , thrombosis , select case , low extremity duplex ultrasonography . If , analysis , evidence confirm increase thrombotic risk , design institute interventional trial . The purpose application fill gap current knowledge regard role race venous thromboembolism , test different methodology study significant health problem , lay groundwork clinical trial development determine whether therapeutic intervention prophylactic anticoagulation beneficial peripartum period patient sickle cell trait .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Sickle Cell Trait</mesh_term>
	<criteria>Peripartum woman ( White , Black ) Hemoglobin AA AS Hispanic ethnicity</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>sickle cell trait</keyword>
	<keyword>thrombosis</keyword>
	<keyword>D-Dimer</keyword>
</DOC>